BR112018068522A2 - novas proteínas derivadas de alfa-1-microglobulina e seu uso - Google Patents

novas proteínas derivadas de alfa-1-microglobulina e seu uso

Info

Publication number
BR112018068522A2
BR112018068522A2 BR112018068522A BR112018068522A BR112018068522A2 BR 112018068522 A2 BR112018068522 A2 BR 112018068522A2 BR 112018068522 A BR112018068522 A BR 112018068522A BR 112018068522 A BR112018068522 A BR 112018068522A BR 112018068522 A2 BR112018068522 A2 BR 112018068522A2
Authority
BR
Brazil
Prior art keywords
microglobulin
alpha
proteins derived
new proteins
new
Prior art date
Application number
BR112018068522A
Other languages
English (en)
Inventor
Edström Hägerwall Anneli
Åkerström Bo
Wester Rosenlöf Lena
Original Assignee
A1M Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A1M Pharma Ab filed Critical A1M Pharma Ab
Publication of BR112018068522A2 publication Critical patent/BR112018068522A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)

Abstract

esta invenção se refere às proteínas derivadas de alfa-1-microglobulina para o uso médico.
BR112018068522A 2016-03-18 2017-03-17 novas proteínas derivadas de alfa-1-microglobulina e seu uso BR112018068522A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201670158 2016-03-18
PCT/EP2017/056436 WO2017158181A1 (en) 2016-03-18 2017-03-17 Novel alpha-1-microglobulin derived proteins and their use

Publications (1)

Publication Number Publication Date
BR112018068522A2 true BR112018068522A2 (pt) 2019-01-22

Family

ID=56080208

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018068522A BR112018068522A2 (pt) 2016-03-18 2017-03-17 novas proteínas derivadas de alfa-1-microglobulina e seu uso

Country Status (15)

Country Link
US (1) US10981963B2 (pt)
EP (1) EP3430032B1 (pt)
JP (1) JP6976579B2 (pt)
KR (1) KR102437662B1 (pt)
CN (1) CN108779157B (pt)
AU (1) AU2017235608B2 (pt)
BR (1) BR112018068522A2 (pt)
CA (1) CA3017836A1 (pt)
EA (1) EA039776B1 (pt)
ES (1) ES2896734T3 (pt)
MX (1) MX2018011193A (pt)
NZ (1) NZ746677A (pt)
SG (1) SG11201807352XA (pt)
WO (1) WO2017158181A1 (pt)
ZA (1) ZA201805797B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3081416A1 (en) * 2017-11-03 2019-05-09 Guard Therapeutics International AB Use of alpha-1-microglobulin for protection of bone marrow cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2313106B1 (en) * 2008-07-18 2016-03-30 A1M Pharma AB Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
US9758554B2 (en) * 2012-01-31 2017-09-12 Technische Universitaet Muenchen Muteins of α1m lipocalin and method of production therefor
CA2881321A1 (en) * 2012-09-05 2014-03-13 A1M Pharma Ab Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases
WO2014047490A1 (en) * 2012-09-21 2014-03-27 Beintoo, S.P.A. Interactive experience fully contained within an expandalble embedded unit
US10226570B2 (en) * 2017-03-10 2019-03-12 Seton Healthcare Family Apparatus and method for temporarily securing a movable accessory device relative to a movable patient

Also Published As

Publication number Publication date
JP6976579B2 (ja) 2021-12-08
EP3430032A1 (en) 2019-01-23
KR20180127411A (ko) 2018-11-28
NZ746677A (en) 2023-02-24
ZA201805797B (en) 2022-03-30
AU2017235608B2 (en) 2020-10-22
EA039776B1 (ru) 2022-03-11
AU2017235608A1 (en) 2018-10-18
WO2017158181A1 (en) 2017-09-21
SG11201807352XA (en) 2018-09-27
ES2896734T3 (es) 2022-02-25
US10981963B2 (en) 2021-04-20
JP2019519466A (ja) 2019-07-11
MX2018011193A (es) 2019-03-28
EA201892085A1 (ru) 2019-02-28
KR102437662B1 (ko) 2022-08-29
CA3017836A1 (en) 2017-09-21
CN108779157A (zh) 2018-11-09
EP3430032B1 (en) 2021-09-01
CN108779157B (zh) 2022-12-30
US20190161524A1 (en) 2019-05-30

Similar Documents

Publication Publication Date Title
CY1124106T1 (el) Συνθεσεις μεταφορεα-αντισωματος και μεθοδοι παρασκευης και χρησης αυτων
CY1122898T1 (el) Απεκκριση πολυπεπτιδιων που περιεχουν αιμη
CR20180013A (es) Anticuerpos anti-tau y métodos de uso.
CL2016001871A1 (es) Anticuerpos humanos para pd-1
CR20190271A (es) Anticuerpos antitau y métodos de uso
BR112017024899A2 (pt) proteínas de ligação trispecíficas e métodos de uso.
CL2017000590A1 (es) Anticuerpos anti-cll-1 e inmunoconjugados
CR20160362A (es) Anticuerpos anti-jagged1 y metodos de uso
CR20170230A (es) Anticuerpos anti-cd79b y métodos de uso
BR112017013608B8 (pt) Picolinamidas como fungicidas
BR112016025397A2 (pt) picolinamidas macrocíclicas como fungicidas
CR20170240A (es) Anticuerpos anti-interleucina-33 y sus usos
CR20160270A (es) ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN
EA201892568A1 (ru) Способы получения контрастных средств для ультразвукового исследования
BR112018012313A2 (pt) composições que compreendem 15-hepe e métodos para uso das mesmas
BR112017004140A2 (pt) sondas para imageamento de proteína de huntingtina
BR112017004136A2 (pt) sondas para imageamento de proteína de huntingtina
BR112017009792A2 (pt) anticorpos anti-pdgf-b e métodos de uso
BR112017002090A2 (pt) formulação de fator viii
DK2897382T3 (da) Forbedring af binaural kilde
AR101671A1 (es) Anticuerpos anti proteína similar a angiopoyetina-4 (angptl4) y métodos de uso
BR112017010700A2 (pt) combinação de ibudilaste e riluzol e métodos de uso da mesma
DK3453718T3 (da) Anvendelse af protein p8 afledt af mælkesyrebakterier som et middel mod cancer
BR112018068522A2 (pt) novas proteínas derivadas de alfa-1-microglobulina e seu uso
DK3383446T3 (da) Fremgangsmåde til inaktivering af xenoantigener i biologiske væv

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: GUARD THERAPEUTICS INTERNATIONAL AB (SE)

B350 Update of information on the portal [chapter 15.35 patent gazette]
B25G Requested change of headquarter approved

Owner name: GUARD THERAPEUTICS INTERNATIONAL AB (SE)

B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]